COMPANY PROFILE

IMPACT Therapeutics

Explore full profile

IMPACT Therapeutics is a China based Company

Nanjing City, ChinaFounded 2009Biotech & Life Sciences

Valuation $500M–1B Last recorded · 2026

Revenue $10–50M Latest reported FY

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About IMPACT Therapeutics

Impact Therapeutics is a biopharmaceutical company focused on developing innovative cancer therapies. The company operates in the oncology market, targeting both patients and healthcare providers. Its business model revolves around the discovery and clinical translation of novel drugs designed to treat various forms of cancer. By integrating drug discovery with clinical trials, Impact Therapeutics aims to bring effective treatments to market more efficiently. The company generates revenue through partnerships, licensing agreements, and the commercialization of its proprietary drugs. Key clients include hospitals, cancer treatment centers, and pharmaceutical companies. Impact Therapeutics leverages its expertise in personalized cancer therapy to improve patient outcomes and advance the field of oncology.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2009
Headquarters: Nanjing City, China
Open positions: 1
Dealroom signal: 25.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Intellectual Property, Biotechnology, Oncology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
IPOOther financing	May 2026	$102M	$726M	Undisclosed	↗
SERIES DOther financing	Nov 2024	$34M	$756M	Undisclosed	↗

Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Growth	EBITDA	Margin
2026
2025		—	—
2024		—	—
2023	—	—	—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

IMPACT Therapeutics website traffic

Latest recorded traffic for IMPACT Therapeutics is 650 monthly website visits, up 47.7% over the last three months.

Latest monthly visits650 3-month web change+47.7%

Monthly website visitsDec 2018–Jun 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

DMPK+Toxicity DirectorNanjing City, Jiangsu, China · Other · Jun 16, 2026

1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
HIHistideBiotech intellectual property platform	Feusisberg, Switzerland	Operational	6	$4.1M	—
QOQUE OncologyNovel therapies to address unmet medical needs in the treatment of cancer and its consequences	Melbourne, Australia	Operational
ANAnchorDxAnchorDx is a precision medicine firm	Guangzhou, China	Operational
MBMabSpace BiosciencesMabSpace Biosciences is a focused on the discovery and development	China	Operational
GEGeneAssessNew jersey-based biotechnology company working to validate fry, a cancer molecular signature gene	New Brunswick, United States	Operational
XBX BODYJuno Therapeutics \| Breakthrough Immunotherapies For Cancer	Waltham, United States	Acquired
CTCrescendo Biologics (Formerly Translocus)Novel T-cell enhancing Humabody® therapeutics for immuno-oncology	Cambridge, United Kingdom	Operational
THTHERAVECTYSTHERAVECTYS develops a platform for the prevention and treatment of cancers and other infectious diseases and conditions.	Paris, France	Operational